4757
-
Vascular Health and Risk Management
-
Dr Pérez-López (Logout)
My Dovepress
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Vascular Health and Risk Management
(1,472,187) Views
Editor in Chief Professor Roland Asmar
Epidemiology, classification, and modifiable risk factors of peripheral arterial diseaseNicolas W Shammas
Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome
Caroline Schmidt-Lucke, Heinz-Peter Schultheiss
Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination
Andreas Pfützner, Birgit Wilhelm, Thomas Forst
Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial
Przemyslaw Kardas
Sirolimus-eluting coronary stents: a review
Alexandre Abizaid
Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data
Kirk A Bronander, Michael J Bloch
Review of sitagliptin phosphate: a novel treatment for type 2 diabetes
Baptist Gallwitz
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
